ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 130 filers reported holding ALLAKOS INC in Q2 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,502 | -47.7% | 14,318 | +0.5% | 0.00% | – |
Q2 2023 | $62,112 | -11.3% | 14,246 | +16.1% | 0.00% | – |
Q1 2022 | $70,000 | -53.3% | 12,273 | -20.3% | 0.00% | – |
Q4 2021 | $150,000 | -91.2% | 15,397 | -3.8% | 0.00% | -100.0% |
Q3 2021 | $1,695,000 | +6.2% | 16,013 | -14.3% | 0.01% | 0.0% |
Q2 2021 | $1,596,000 | -2.6% | 18,692 | +31.0% | 0.01% | 0.0% |
Q1 2021 | $1,638,000 | -15.9% | 14,273 | +2.6% | 0.01% | -28.6% |
Q4 2020 | $1,948,000 | +120.1% | 13,916 | +28.0% | 0.01% | +75.0% |
Q3 2020 | $885,000 | +10.9% | 10,869 | -2.1% | 0.00% | 0.0% |
Q2 2020 | $798,000 | +128.7% | 11,103 | +41.5% | 0.00% | +33.3% |
Q1 2020 | $349,000 | -72.2% | 7,846 | -40.4% | 0.00% | -50.0% |
Q4 2019 | $1,255,000 | +4.1% | 13,164 | -14.1% | 0.01% | -14.3% |
Q3 2019 | $1,205,000 | +97.2% | 15,323 | +8.7% | 0.01% | +75.0% |
Q2 2019 | $611,000 | -4.8% | 14,099 | -11.0% | 0.00% | 0.0% |
Q1 2019 | $642,000 | -18.9% | 15,850 | +4.6% | 0.00% | -33.3% |
Q4 2018 | $792,000 | – | 15,159 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 4,887,932 | $561,037,000 | 86.41% |
Fairmount Funds Management LLC | 147,662 | $16,949,000 | 7.14% |
NEA Management Company, LLC | 2,164,704 | $248,465,000 | 5.58% |
Redmile Group, LLC | 2,419,418 | $277,701,000 | 3.91% |
Samsara BioCapital, LLC | 146,259 | $16,788,000 | 3.10% |
Samsara BioCapital, LLC | 83,000 | $9,527,000 | 1.76% |
Rock Springs Capital Management LP | 305,706 | $35,089,000 | 0.77% |
Tekla Capital Management LLC | 163,645 | $18,783,000 | 0.65% |
Legal Advantage Investments, Inc. | 7,000 | $803,000 | 0.60% |
Eventide Asset Management | 317,000 | $36,385,000 | 0.54% |